Fractionated radioimmunotherapy in NHL with DOTA-conjugated, humanized anti-CD22 IgG, epratuzumab: Results at high cumulative doses of 90Y

Authors :: Jean Luc Harousseau
Nick Teoh
Jean-François Chatal
William A. Wegener
Damien Huglo
Françoise Kraeber-Bodéré
F. Morschhauser
David M. Goldenberg
Marie-Odile Petillon
Heather Horne
Source :: Journal of Clinical Oncology. 26:8502-8502
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 8502 Background: A phase I/II, multi-center, dose-escalation trial was undertaken to determine the maximum tolerated dose (MTD) for fractionated radioimmunotherapy with 2 or 3 weekly infusions of 9...

Subjects :: Cancer Research
business.industry
medicine.medical_treatment
Pharmacology
Conjugated system
chemistry.chemical_compound
Anti-CD22 IgG
Oncology
chemistry
Maximum tolerated dose
Radioimmunotherapy
medicine
DOTA
business
Epratuzumab
medicine.drug

Full Text Access

Tools